Goal 2: Reduce Human Disease

Can we safely move CAR therapy i beyond limited academic centers?

CAR therapy has resurrected the role of immunotherapy in treating cancer. But it has significant toxicity. Can we train , standardize the care of and adequately oversee the care of patients getting CAR therapy , especially as company begin to approach FDA for approval of this therapy and up scale for mass treatment.

Is this idea a Compelling Question (CQ) or Critical Challenge (CC)? Critical Challenge (CC)

Details on the impact of addressing this CQ or CC

To optimize care of CARpatients

Feasibility and challenges of addressing this CQ or CC

Cooperative group cooperation and large community cancer care centers . Adequate funding to support the endeavor

Name of idea submitter and other team members who worked on this idea Leoan A Holmberg MD, PhD

Tags (Keywords associated with the idea)

Annotations

Voting

11 net votes
26 up votes
15 down votes
Active
Idea No. 564